Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2026-02-17 @ 3:57 PM
Study NCT ID:
NCT07293468
Status:
RECRUITING
Last Update Posted:
2025-12-19
First Post:
2024-12-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)
Sponsor:
Tuen Mun Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatocellular Carcinoma (HCC) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | TACE | View |
| None | SBRT | View |
| None | Y90 | View |
| None | SIRT | View |
| None | immunotherapy | View |
| None | combination therapy | View |
| None | locally advanced | View |
| None | unresectable HCC | View |
| None | RCT | View |
| None | liver | View |
| None | hepatocellular carcinoma | View |
| None | stereotactic body radiotherapy | View |
| None | transarterial chemoembolization | View |
| None | radioembolization | View |